Hautarztpraxis Dr. Bong
Industry / private company
Location:
Emmerich am Rhein,
Germany (DE)
Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis (2026)
Kind B, Pham C, Heinrich L, Honstein T, Heratizadeh A, Harder I, Stölzl D, et al.
Journal article
Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry (2026)
Traidl S, Cornelius A, Heinrich L, Siegels D, Zacharias H, Heratizadeh A, Honstein T, et al.
Journal article
Patient treatment needs in atopic dermatitis: A real-world cohort study (2026)
Ludemann K, Traidl S, Cornelius A, Naim J, Heratizadeh A, Honstein T, Kind B, et al.
Journal article
Large Eczema Area and Severity Index response at 2-year follow-up of patients treated with dupilumab in routine care of atopic dermatitis: results from the national registry TREATgermany (2025)
Heinrich L, Birkner T, Abraham S, Gerdes S, Honstein T, Müller S, Augustin M, et al.
Journal article
Obesity is linked to disease severity in moderate to severe atopic dermatitis—Data from the prospective observational TREATgermany registry (2024)
Traidl S, Hollstein MM, Kroeger N, Fischer S, Heratizadeh A, Heinrich L, Kind B, et al.
Journal article